Discussion of Alleviating Digestive Medication Toxicity in S-1 Administered Patients— Retrospective and Comparative Study of the Health Records of Continuously-administered Patients and withdrawal Patients

Author： Nakao Koji   Fujii Hirohisa  

Publisher： Sunmedia

ISSN： 0385-0684

Source： Japanese Journal of Cancer and Chemotherapy, Vol.36, Iss.3, 2009-03, pp. : 443-446

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer

By Zhu Andrew   Clark Jeffrey   Ryan David   Meyerhardt Jeffrey   Enzinger Peter   Earle Craig   Fuchs Charles   Regan Eileen   Anbe Hiroshi   Houghton Michele   Zhang Joshua   Urrea Peter   Kulke Matthew  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 3, 2007-03 ,pp. : 285-293

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis

By Sakamoto Takeshi   Yasui Hirofumi   Boku Narikazu   Onozawa Yusuke   Hironaka Shuichi   Fukutomi Akira   Yamazaki Kentaro   Taku Keisei   Machida Nozomu   Todaka Akiko   Tomita Hideharu   Tsushima Takahiro   Taniguchi Hiroya   Hamauchi Satoshi  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 287-293

Springer Publishing Company

Access to resources Recommend Favorite

An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours

By Awada A.   Thodtmann R.   Piccart M.J.   Wanders J.   Schrijvers A.H.G.J.   Von Broen I.-M.   Hanauske A.R.  

European Journal of Cancer, Vol. 39, Iss. 6, 2003-04 ,pp. : 742-747

Elsevier

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma

By Ueno Hideki   Okada Shuichi   Okusaka Takuji   Ikeda Masafumi   Kuriyama Hitoshi  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 155-160

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors

By Nemunaitis John   Mita Alain   Stephenson Joe   Mita Monica   Sarantopoulos John   Padmanabhan-Iyer Swami   Nanda Nisha   Gleich Lyon   Benichou Annie-Claude   Craig Adam  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 35-41

Springer Publishing Company

Access to resources Recommend Favorite